Clitoral atrophy: a case series.
BACKGROUND
Clitoral atrophy is often a neglected cause of female arousal complaints and warrants treatment with localized treatments.


OBJECTIVE
This is a case series of patients with clitoral atrophy in which localized estrogens were used to treat separate, distinct sexual complaints.


METHODS
We report on three patients who were treated with localized estrogen tablets and cream for symptomatic clitoral atrophy despite a lack of data for use of these agents for the treatment of this diagnosis. The patients described here expressed understanding of the risks of vaginal hormonal therapy prior to treatment and at follow-up visits while on therapy.


METHODS
Patient reports, physical examination, and vaginal pH.


RESULTS
All patients reported improvement or resolution of symptoms after the treatment with localized estrogen tablets and/or cream.


CONCLUSIONS
Low-dose minimally absorbed local estrogen products can be used in combination with excellent tolerance and low side-effect profile to treat female sexual complaints.
Amsterdam
Alison
A
Deparmtent of Surgery, Division of Gynecology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. ada2@cornell.edu
Krychman
Michael
M
D000282:Administration, Intravaginal; D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D001284:Atrophy / Q000473:pathology / Q000628:therapy; D002626:Chemistry, Pharmaceutical; D002987:Clitoris / Q000473:pathology*; D004967:Estrogens / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged
D004967:Estrogens